| Year |
Citation |
Score |
| 2019 |
Choquette D, Bessette L, Sauvageau LC, Ferdinand I, Haraoui P, Massicotte F, Pelletier J, Raynauld J, Rémillard M, Sauvageau D, Villeneuve É, Coupal L. Fri0084 The Impact Of Il-6 And Tnf Inhibitors On Hemoglobin Levels: An Analysis From Rhumadata® Clinical Database And Registry Annals of the Rheumatic Diseases. 78: 705-705. DOI: 10.1136/Annrheumdis-2019-Eular.4161 |
0.338 |
|
| 2019 |
Choquette D, Bessette L, Sauvageau LC, Ferdinand I, Haraoui P, Massicotte F, Pelletier J, Raynauld J, Rémillard M, Sauvageau D, Villeneuve É, Coupal L. Ab0740 Use Of Secukinumab In Patients With Psoriatic Arthritis. Impacts Of Combination With Methotrexate Annals of the Rheumatic Diseases. 78: 1835-1835. DOI: 10.1136/Annrheumdis-2019-Eular.3132 |
0.303 |
|
| 2019 |
Choquette D, Bessette L, Sauvageau LC, Ferdinand I, Haraoui P, Massicotte F, Pelletier J, Raynauld J, Rémillard M, Sauvageau D, Villeneuve É, Coupal L. Sat0120 Comparative Effectiveness Of Tofacitinib And Tnf Inhibitors Since 2014. Impact Of Combination With Methotrexate Annals of the Rheumatic Diseases. 78: 1128-1128. DOI: 10.1136/Annrheumdis-2019-Eular.3110 |
0.316 |
|
| 2017 |
Choquette D, Bessette L, Alemao E, Haraoui B, Massicotte F, Mtibaa M, Muratti E, Pelletier J, Postema R, Raynauld J, Rémillard M, Sauvageau D, Turcotte A, Villeneuve Έ, Coupal L. SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry Annals of the Rheumatic Diseases. 76: 1188-1188. DOI: 10.1136/Annrheumdis-2017-Eular.2379 |
0.307 |
|
| 2017 |
Choquette D, Bessette L, Alemao E, Haraoui B, Massicotte F, Mtibaa M, Muratti E, Pelletier J, Postema R, Raynauld J, Rémillard M, Sauvageau D, Turcotte A, Villeneuve Έ, Coupal L. FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry Annals of the Rheumatic Diseases. 76: 571-572. DOI: 10.1136/Annrheumdis-2017-Eular.2326 |
0.323 |
|
| 2016 |
Raynauld J-, Bessette L, Brown J, Coupal L, Haraoui B, Massicotte F, Pelletier J-, Rémillard M-, Sauvageau D, Villeneuve Έ, Choquette D. THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry Annals of the Rheumatic Diseases. 75: 190-190. DOI: 10.1136/Annrheumdis-2016-Eular.3628 |
0.301 |
|
| 2016 |
Bessette L, Brown J, Coupal L, Haraoui B, Massicotte F, Pelletier J-, Raynauld J-, Rémillard M-, Sauvageau D, Villeneuve Έ, Choquette D. THU0035 Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from The Provincial Electronic Database and Registry Rhumadata® Annals of the Rheumatic Diseases. 75: 190-190. DOI: 10.1136/Annrheumdis-2016-Eular.1605 |
0.306 |
|
| 2006 |
Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy. 8: R177. PMID 17129375 DOI: 10.1186/Ar2087 |
0.665 |
|
| 2006 |
Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone. 38: 333-41. PMID 16257278 DOI: 10.1016/J.Bone.2005.09.007 |
0.695 |
|
| 2003 |
Lajeunesse D, Massicotte F, Pelletier JP, Martel-Pelletier J. Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Modern Rheumatology / the Japan Rheumatism Association. 13: 7-14. PMID 24387110 DOI: 10.3109/S101650300001 |
0.673 |
|
| 2003 |
Guévremont M, Martel-Pelletier J, Massicotte F, Tardif G, Pelletier JP, Ranger P, Lajeunesse D, Reboul P. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 1073-81. PMID 12817761 DOI: 10.1359/Jbmr.2003.18.6.1073 |
0.698 |
|
| 2003 |
Reboul P, Guévremont M, Martel-Pelletier J, Massicotte F, Ranger P, Pelletier J, Lajeunesse D. Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat Arthritis Research & Therapy. 5: 162-162. DOI: 10.1186/Ar963 |
0.693 |
|
| 2003 |
Lajeunesse D, Massicotte F, Aubry I, Martel-Pelletier J, Pelletier J. Arthritis Research & Therapy. 5: 63. DOI: 10.1186/Ar864 |
0.659 |
|
| 2002 |
Paredes Y, Massicotte F, Pelletier JP, Martel-Pelletier J, Laufer S, Lajeunesse D. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis and Rheumatism. 46: 1804-12. PMID 12124864 DOI: 10.1002/Art.10357 |
0.605 |
|
| 2002 |
Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, Martel-Pelletier J. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 10: 491-500. PMID 12056853 DOI: 10.1053/Joca.2002.0528 |
0.566 |
|
| 2001 |
Hilal G, Massicotte F, Martel-Pelletier J, Fernandes JC, Pelletier JP, Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 16: 713-21. PMID 11315999 DOI: 10.1359/Jbmr.2001.16.4.713 |
0.664 |
|
| Show low-probability matches. |